Loading…
Reported covered position: Did not lobby the Senate; Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
RECYCLING LEADERSHIP COUNCIL via S-3 GROUP
2026 · third_quarter · Q3
Issues pertaining to advanced recycling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via S-3 GROUP
2026 · third_quarter · Q3
Source: Senate LDA
| ALLIANCE OF COMMUNITY HEALTH PLANS |
| 17 |
| 2023–2026 |
| ALZHEIMER'S ASSOCIATION | 17 | 2019–2022 |
| DOORDASH | 17 | 2023–2026 |
| NATIONAL BUSINESS AVIATION ASSOCIATION | 17 | 2022–2026 |
| PITNEY BOWES | 17 | 2022–2026 |
| AMERICAN OPTOMETRIC ASSOCIATION | 16 | 2023–2026 |
| S&P GLOBAL | 16 | 2019–2022 |
| BAXTER HEALTHCARE CORPORATION | 15 | 2023–2026 |
| NATIONAL FOOTBALL LEAGUE | 15 | 2022–2026 |
| THE INTERNET ASSOCIATION | 15 | 2019–2021 |
| MILITARY HOUSING ASSOCIATION | 14 | 2019–2021 |
| SANDOZ INC. | 14 | 2023–2026 |
| ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION | 13 | 2023–2026 |
| DRUM MAJORS FOR CHANGE | 13 | 2023–2026 |
| THE BOEING COMPANY | 12 | 2019–2021 |
| BLOCKCHAIN ASSOCIATION | 11 | 2018–2020 |
| NATIONAL MUSEUM OF WOMEN IN THE ARTS | 11 | 2019–2020 |
| U.S. SUGAR CORPORATION | 11 | 2019–2022 |
| SAP AMERICA INC. | 10 | 2019–2021 |
| HOLISTIC INDUSTRIES INC. | 9 | 2021–2023 |
| PET FOOD INSTITUTE | 9 | 2024–2026 |
| GENERAL MOTORS | 8 | 2021–2022 |
| LEGO SYSTEMS, INC. | 8 | 2023–2025 |
| DAVITA, INC. | 7 | 2025–2026 |
| GOODRX | 7 | 2025–2026 |
| KARSAN USA, LLC | 7 | 2019 |
| MCKINSEY & COMPANY | 6 | 2025–2026 |
| SINCLAIR BROADCAST GROUP | 6 | 2019 |
| T-MOBILE USA, INC. | 6 | 2022–2023 |
| AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. | 5 | 2026 |
| GOOGLE CLIENT SERVICES LLC | 5 | 2021–2022 |
| LVMH MOET HENNESSY LOUIS VUITTON INC. | 5 | 2021–2022 |
| AMERICAN EXPLORATION & PRODUCTION COUNCIL | 4 | 2025–2026 |
| AMERICAN PETROLEUM INSTITUTE | 4 | 2025–2026 |
| CONOCOPHILLIPS | 4 | 2026 |
| GENENTECH | 4 | 2019–2020 |
| NOVO NORDISK, INC. | 4 | 2026 |
| ORCHARD THERAPEUTICS NORTH AMERICA | 4 | 2025–2026 |
| RECYCLING LEADERSHIP COUNCIL | 4 | 2026 |
| WAYMO LLC | 4 | 2025–2026 |
| ADVOCARE, LLC | 3 | 2020 |
| AMAG PHARMACEUTICALS, INC. | 3 | 2020 |
| GENEVANT SCIENCES, INC. | 3 | 2023 |
| PACE GALLERY | 3 | 2020 |
| COHESITY, INC. | 2 | 2026 |
| SKYDIO, INC. | 1 | 2026 |
Dental and Optometric Care Access Act; Vision Lab Choice Act S 1716
Dental and Optometric Care Access Act; Vision Lab Choice Act S 1716
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Protect Our Letter Carriers Act of 2024
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 - Postal Service Reform Act of 2021; S.1720 - Postal Service Reform Act of 2021
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to financial assistance to the aviation industry, including S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act
Issues related to financial assistance to the aviation industry, including S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Postal Service Reform Act of 2022
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Auto Industry issues, including sharing information about GM products and facilities; fuel economy; EV Tax Credit; Build Back Better Act, H.R. 5376; funding for semiconductor manufacturing, United States Innovation and Competition Act of 2021, S. 1260
Postal Service Reform Act of 2021
Client: NATIONAL ASSOCIATION OF LETTER CARRIERS · Firm: S-3 GROUP
General Postal issues; H.R. 3076 Postal Service Reform Act of 2021; S. 1720 Postal Service Reform Act of 2021
Issues related to funding Alzheimers research and education, including H.R.1873 - Improving HOPE for Alzheimer's Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to technology and internet business, including S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act and issues related to the cloud
Issues related to technology and internet business, including S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act and issues related to the cloud
Issues related to technology and internet business, including S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act and issues related to the cloud
Issues related to technology and internet business, including S.3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act and issues related to the cloud
Dodd-Frank Implementation and issues related to credit rating agencies and commodity/ financial derivatives and benchmarks; Issues related to the pricing of aluminum - S.1953 and H.R.1406
Issues related to funding Alzheimers research and education, including H.R.1873 - Improving HOPE for Alzheimer's Act
Issues related to funding Alzheimers research and education, including H.R.1873 - Improving HOPE for Alzheimer's Act.
Issues related to funding Alzheimers research and education, including H.R.1873 - Improving HOPE for Alzheimer's Act
Issues related to funding Alzheimers research and education, including H.R.1873 - Improving HOPE for Alzheimer's Act
Issues related to distributed financial systems and decentralized web applications using blockchain and related distributed ledger technologies, including the Token Taxonomy Act H.R. 2144
Issues related to distributed financial systems and decentralized web applications using blockchain and related distributed ledger technologies, including the Token Taxonomy Act H.R. 2144
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to tariffs and importation of counterfeit drugs.
Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing.
Issues related to compounding and counterfeit drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues regarding permitting reform
Issues regarding permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to privacy, data security, and funding
Issues related to privacy and data security
Issues related to privacy, data security, and funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding lower prescription drug prices for patients
Issues regarding lower prescription drug prices for patients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to reimbursement for psychologists in designated health professional shortage areas; and issues related to reimbursement for psychological and neuropsychological testing in Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via S-3 GROUP
2026 · third_quarter · Q3
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN EXPLORATION & PRODUCTION COUNCIL via S-3 GROUP
2026 · third_quarter · Q3
Monitor issues and legislation to support the resonsible production of American oil and gas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUM MAJORS FOR CHANGE via S-3 GROUP
2026 · third_quarter · Q3
Voting rights and civil rights issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
Promote kidney care and positive patient outcomes
Issues relating to safe mobility; issues relating to pandemic all-hazards preparedness act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · third_quarter · Q3
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via S-3 GROUP
2026 · third_quarter · Q3
Dental and Optometric Care Access Act; Vision Lab Choice Act S 1716
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PET FOOD INSTITUTE via S-3 GROUP
2026 · third_quarter · Q3
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSEY & COMPANY via S-3 GROUP
2026 · third_quarter · Q3
Raising awareness related to company activities and business
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION via S-3 GROUP
2026 · third_quarter · Q3
Advocating for electronic labeling for prescribers only
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Postal issues related to mailing and shipping
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF LETTER CARRIERS via S-3 GROUP
2026 · third_quarter · Q3
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST FIVE ACTION FUND via S-3 GROUP
2026 · third_quarter · Q3
Child care issues before Congress
Child care issues before Congress
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PETROLEUM INSTITUTE via S-3 GROUP
2026 · third_quarter · Q3
Issues concerning oil and gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to Rx drug pricing
Issues related to health care research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER BRANDS ASSOCIATION via S-3 GROUP
2026 · third_quarter · Q3
Consumer packaged goods and sustainability and recyclability of packaged goods
Issues related to the food and beverage industries
Issues related to the food and beverage industries
DUKE ENERGY CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
NATIONAL BUSINESS AVIATION ASSOCIATION via S-3 GROUP
2026 · third_quarter · Q3
Issues related to financial assistance to the aviation industry, including Coronavirus Aid, Relief, and Economic Security
Legislative efforts relating to general aviation and FAA reauthorization issues
Legislative efforts relating to the budget and tax reform that could impact general aviation and FAA reauthorization issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · fourth_quarter · RR
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. via S-3 GROUP
2026 · second_quarter · 2A
Issues related to reimbursement for psychologists in designated health professional shortage areas; and issues related to reimbursement for psychological and neuropsychological testing in Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. via S-3 GROUP
2026 · second_quarter · 2A
Issues related to reimbursement for psychologists in designated health professional shortage areas; and issues related to reimbursement for psychological and neuropsychological testing in Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RECYCLING LEADERSHIP COUNCIL via S-3 GROUP
2026 · second_quarter · Q2
Issues pertaining to advanced recycling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to tariffs and importation of counterfeit drugs.
Issues related to compounding and counterfeit drugs.
Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues regarding permitting reform
Issues regarding permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to privacy, data security, and funding
Issues related to privacy, data security, and funding
Issues related to privacy and data security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding lower prescription drug prices for patients
Issues regarding lower prescription drug prices for patients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to reimbursement for psychologists in designated health professional shortage areas; and issues related to reimbursement for psychological and neuropsychological testing in Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via S-3 GROUP
2026 · second_quarter · Q2
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN EXPLORATION & PRODUCTION COUNCIL via S-3 GROUP
2026 · second_quarter · Q2
Monitor issues and legislation to support the resonsible production of American oil and gas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUM MAJORS FOR CHANGE via S-3 GROUP
2026 · second_quarter · Q2
Voting rights and civil rights issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
Issues relating to safe mobility; issues relating to pandemic all-hazards preparedness act
Promote kidney care and positive patient outcomes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · second_quarter · Q2
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via S-3 GROUP
2026 · second_quarter · Q2
Dental and Optometric Care Access Act; Vision Lab Choice Act S 1716
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PET FOOD INSTITUTE via S-3 GROUP
2026 · second_quarter · Q2
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSEY & COMPANY via S-3 GROUP
2026 · second_quarter · Q2
Raising awareness related to company activities and business
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION via S-3 GROUP
2026 · second_quarter · Q2
Advocating for electronic labeling for prescribers only
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Postal issues related to mailing and shipping
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF LETTER CARRIERS via S-3 GROUP
2026 · second_quarter · Q2
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST FIVE ACTION FUND via S-3 GROUP
2026 · second_quarter · Q2
Child care issues before Congress
Child care issues before Congress
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PETROLEUM INSTITUTE via S-3 GROUP
2026 · second_quarter · Q2
Issues concerning oil and gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to health care research
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER BRANDS ASSOCIATION via S-3 GROUP
2026 · second_quarter · Q2
Issues related to the food and beverage industries
Issues related to the food and beverage industries
Consumer packaged goods and sustainability and recyclability of packaged goods
DUKE ENERGY CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
NATIONAL BUSINESS AVIATION ASSOCIATION via S-3 GROUP
2026 · second_quarter · Q2
Issues related to financial assistance to the aviation industry, including Coronavirus Aid, Relief, and Economic Security
Legislative efforts relating to general aviation and FAA reauthorization issues
Legislative efforts relating to the budget and tax reform that could impact general aviation and FAA reauthorization issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RECYCLING LEADERSHIP COUNCIL via S-3 GROUP
2026 · first_quarter · Q1
Issues pertaining to advanced recycling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing.
Issues related to tariffs and importation of counterfeit drugs.
Issues related to compounding and counterfeit drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues regarding permitting reform
Issues regarding permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding lower prescription drug prices for patients
Issues regarding lower prescription drug prices for patients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues related to reimbursement for psychologists in designated health professional shortage areas; and issues related to reimbursement for psychological and neuropsychological testing in Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via S-3 GROUP
2026 · first_quarter · Q1
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN EXPLORATION & PRODUCTION COUNCIL via S-3 GROUP
2026 · first_quarter · Q1
Monitor issues and legislation to support the resonsible production of American oil and gas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUM MAJORS FOR CHANGE via S-3 GROUP
2026 · first_quarter · Q1
Voting rights and civil rights issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via S-3 GROUP
2026 · first_quarter · Q1
Promote kidney care and positive patient outcomes
Issues relating to safe mobility; issues relating to pandemic all-hazards preparedness act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · first_quarter · Q1
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via S-3 GROUP
2026 · first_quarter · Q1
Dental and Optometric Care Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PET FOOD INSTITUTE via S-3 GROUP
2026 · first_quarter · Q1
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSEY & COMPANY via S-3 GROUP
2026 · first_quarter · Q1
Raising awareness related to company activities and business
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION via S-3 GROUP
2026 · first_quarter · Q1
Advocating for electronic labeling for prescribers only
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Postal issues related to mailing and shipping
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF LETTER CARRIERS via S-3 GROUP
2026 · first_quarter · Q1
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST FIVE ACTION FUND via S-3 GROUP
2026 · first_quarter · Q1
Child care issues before Congress
Child care issues before Congress
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PETROLEUM INSTITUTE via S-3 GROUP
2026 · first_quarter · Q1
Issues concerning oil and gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · first_quarter · Q1
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to health care research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER BRANDS ASSOCIATION via S-3 GROUP
2026 · first_quarter · Q1
Issues related to the food and beverage industries
Issues related to the food and beverage industries
Consumer packaged goods and sustainability and recyclability of packaged goods
DUKE ENERGY CORPORATION via S-3 GROUP
2026 · first_quarter · Q1
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
NATIONAL FOOTBALL LEAGUE via S-3 GROUP
2026 · first_quarter · Q1
Legislative and regulatory issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BUSINESS AVIATION ASSOCIATION via S-3 GROUP
2026 · first_quarter · Q1
Issues related to financial assistance to the aviation industry, including Coronavirus Aid, Relief, and Economic Security
Legislative efforts relating to general aviation and FAA reauthorization issues
Legislative efforts relating to the budget and tax reform that could impact general aviation and FAA reauthorization issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RECYCLING LEADERSHIP COUNCIL via S-3 GROUP
2026 · first_quarter · RR
Issues pertaining to advanced recycling
NOVO NORDISK, INC. via S-3 GROUP
2026 · first_quarter · RR
Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.
Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.
Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.
2026 · first_quarter · RR
Issues related to permitting reform
Issues related to permitting reform
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding lower prescription drug prices for patients
Issues regarding lower prescription drug prices for patients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUM MAJORS FOR CHANGE via S-3 GROUP
2025 · fourth_quarter · Q4
Voting rights and civil rights issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2025 · fourth_quarter · Q4
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, and PBM reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via S-3 GROUP
2025 · fourth_quarter · Q4
Dental and Optometric Care Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION via S-3 GROUP
2025 · fourth_quarter · Q4
Advocating for electronic labeling for prescribers only
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Postal issues related to mailing and shipping
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF LETTER CARRIERS via S-3 GROUP
2025 · fourth_quarter · Q4
General Postal issues; H.R. 7629 - Protect Our Letter Carriers Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST FIVE ACTION FUND via S-3 GROUP
2025 · fourth_quarter · Q4
Child care issues before Congress
Child care issues before Congress
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PETROLEUM INSTITUTE via S-3 GROUP
2025 · fourth_quarter · Q4
Issues concerning oil and gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2025 · fourth_quarter · Q4
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to health care research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the food and beverage industries
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to the food and beverage industries
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the food and beverage industries
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Regulatory issues confronting the electric utility and natural gas sectors
Regulatory issues confronting the electric utility and natural gas sectors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE